Scinovex
review Open Access

Aloe vera as a new treatment modality for management of chemotherapy-induced oral mucositis in patients with acute leukemia: A review article

International Journal of Applied Dental Sciences · 2024 · Vol. 10(4) · pp. 39–42

Abstract

Leukemia is the most common hematological malignancy in children, particularly acute lymphoblastic leukemia (ALL), which often requires high doses of methotrexate, increasing the risk of oral mucositis (OM). OM is a painful side effect that negatively affects children’s quality of life and treatment adherence. Effective management is important and includes maintaining good oral hygiene, topical agents and pain relief. Recent advancements, such as cryotherapy, low-level laser therapy (LLLT), and natural substances like honey and olive oil, have shown promise in reducing the occurance and grade of OM. Additionally, growth factors like palifermin are emerging as protective options for mucosal protection. Recently Aloe vera is one of the herbal agents known for its healing properties, has gained attention as a potential therapeutic agent for CIOM. Aloe vera possesses anti-inflammatory, antioxidant, and antimicrobial properties, which may help alleviate symptoms and promote healing of the oral mucosa. This reviews focus on the efficacy of Aloe vera and Recent advancements in managing CIOM in children.

Oral health in cancer treatmentHematopoietic Stem Cell TransplantationChemotherapy-related skin toxicityMucositisMedicineAloe veraAcute leukemiaChemotherapyLeukemiaTreatment modalityIntensive care medicineDermatologyInternal medicine
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
38%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Aloe vera as a new treatment modality for management of chemotherapy-induced oral mucositis in patients with acute leukemia: A review article · Scinovex